DANSKE BANK A/S

Bank

Position in INCY — Incyte Corp

CIK 800177 COPENHAGEN V, G7

Position in INCY

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$7,255,239

-$3,369,547 QoQ

Shares Held

77,085

-28.3% QoQ

Ownership

0.039%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 77.37951611857041.ToString("F0")% Shared 0.ToString("F0")% None 22.62048388142959.ToString("F0")%

Healthcare · as of Mar 31, 2026

DANSKE BANK A/S holds $231,483,953 across 60 Biotechnology names. INCY ranks #6 (3.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	107,220	$82,842,459
2	VRTX	Vertex Pharmaceuticals Inc / Ma	153,006	$68,323,298
3	RPRX	Royalty Pharma plc	588,426	$28,226,795
4	ALNY	Alnylam Pharmaceuticals, Inc.	65,955	$21,822,529
5	INSM	INSMED Inc	111,058	$18,160,204
6	INCY	Incyte Corp This page	77,085	$7,255,239
7	RVMD	Revolution Medicines, Inc.	44,900	$4,366,525
8	BMRN	Biomarin Pharmaceutical Inc	3,000	$169,470

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$7,255,239	77,085	-28.3%	Shares	Sole	2026-05-12
2025-12-31	$10,624,786	107,571	+29.1%	Shares	Sole	2026-02-02
2025-09-30	$7,064,078	83,293	-20.3%	Shares	Sole	2025-11-19
2025-06-30	$7,120,671	104,562	+57.3%	Shares	Sole	2025-12-18
2025-03-31	$4,024,092	66,459	-2.1%	Shares	Sole	2025-12-18
2024-12-31	$4,687,020	67,859	+4.1%	Shares	Sole	2026-03-18
2024-09-30	$4,307,009	65,159	-43.8%	Shares	Sole	2026-03-18
2024-06-30	$7,033,131	116,020	-58.6%	Shares	Sole	2026-03-18
2024-03-31	$15,968,291	280,293	—	Shares	Sole	2026-03-18
No filing history on record for this holder in this stock.